Almotriptan drug interactions: Difference between revisions

Revision as of 02:10, 5 February 2014

Almotriptan
AXERT^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Do not use Almotriptan and ergotamine-containing or ergot-type medications within 24 hours of each other
Do not use Almotriptan and other 5-HT1 agonists (e.g., triptans) within 24 hours of each other
SSRI or SNRI: life-threatening serotonin syndrome reported during combined use with triptans
Ketoconazole: use single dose of Almotriptan 6.25 mg; maximum Almotriptan daily dose 12.5 mg

@@ Line 5: / Line 5: @@
 ==Drug Interactions==
+* Do not use Almotriptan and ergotamine-containing or ergot-type medications within 24 hours of each other
+* Do not use Almotriptan and other 5-HT1 agonists (e.g., [[triptans]]) within 24 hours of each other
+* [[SSRI]] or [[SNRI]]: life-threatening [[serotonin syndrome]] reported during combined use with [[triptans]]
+* [[Ketoconazole]]: use single dose of Almotriptan 6.25 mg; maximum Almotriptan daily dose 12.5 mg
 ==References==
@@ Line 12: / Line 14: @@
 {{Reflist|2}}
-[[Category:AntiMigaraineDrugs]]
 [[Category:Drugs]]